Skip to main content
. 2018 Jul 13;72(8):1159–1166. doi: 10.1038/s41430-018-0256-1

Table 2.

Comparison of treatments between patients with n-3 FA group and control group

Before matched After matched
treatments N-3 fatty group (n = 106) Control group (n = 120) P-value N-3 fatty group (n = 54) Control group (n = 54) P-value
Surgical procedures <0.001 0.169
PTCDa 28(26.4) 70(58.3) 24(44.4) 22(40.8)
ENBDb 4(3.8) 2(1.6) 2(3.6) 2(3.7)
LC or LBDEc 22(20.7) 10(8.4) 6(11.1) 6(11.1)
CBDEd 12(11.3) 4(3.3) 4(7.4) 5(9.3)
OCTDe 12(11.3) 22(18.3) 13(24) 8(14.8)
Bypass surgery 2(1.9) 2(1.7) 2(3.6) 2(3.7)
PDf 26(24.5) 10(8.4) 3(5.5) 9(16.7)
Anastomotic methods <0.001 0.926
PTCD ± ENBD 32(30.2) 72(60) 26(48.2) 24(44.4)
External drainage surgery 34(32) 14(11.7) 10(18.5) 11(30.4)
Bypass surgery 40(37.8) 34(28.3) 18(33.3) 19(35.2)

PTCD percutaneous transhepatic cholangial drainage, ENBD bendoscopic nasobiliary drainage, LC laparoscopic cholecystectomy, LBDE laparoscopic common bile duct exploration, CBDE laparotomy common bile duct exploration, OCTD open choledochotomy T-tube drainage, PD bypass surgery and pancreaticoduodenectomy